3681 - 3690 of 9118 Results
Title
Year
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases2016OPENTitle: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPasesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.12813Best OA location URL: https://doi.org/10.7554/elife.12813Citation Count: 1079
-
OPENTitle: Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson’s diseaseJournal Name: Cytokine: XPublisher: Elsevier BVVol: 2Issue #: 2Start Page: 100027End Page: 100027Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cytox.2020.100027Best OA location URL: https://doi.org/10.1016/j.cytox.2020.100027Citation Count: 48
-
OPENTitle: Movement disorders in non-encephalopathic Hashimoto's thyroiditisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 141End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.008Best OA location URL: https://zenodo.org/record/3873759Citation Count: 17
- Importance of the initial response to GPi deep brain stimulation in dystonia: A nine year quality of life study2019RESTRICTEDTitle: Importance of the initial response to GPi deep brain stimulation in dystonia: A nine year quality of life studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 249End Page: 255Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.04.024Citation Count: 31
- No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome2009OPENTitle: No evidence for cognitive dysfunction or depression in patients with mild restless legs syndromeJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 12Start Page: 1843End Page: 1847Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22701Best OA location URL: http://doi.org/10.1002/mds.22701Citation Count: 75
-
OPENTitle: Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s DiseaseJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 15Issue #: 5Start Page: 8592End Page: 8609Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.1c00453Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsnano.1c00453Citation Count: 101
-
OPENTitle: International Genetic Testing and Counseling Practices for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1527End Page: 1535Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29442Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10461455/pdf/nihms-1897358.pdfCitation Count: 16
- Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats2011RESTRICTEDTitle: Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 62Issue #: 2Start Page: 1052End Page: 1061Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2011.10.016Citation Count: 24
- Risk of Parkinson's disease dementia related to level I MDS PD‐MCI2019OPENTitle: Risk of Parkinson's disease dementia related to level I MDS PD‐MCIJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 3Start Page: 430End Page: 435Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27617Citation Count: 65
-
OPENTitle: Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3Journal Name: neurogeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 121End Page: 133Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s10048-017-0514-8Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs10048-017-0514-8.pdfCitation Count: 78